2004
DOI: 10.1007/bf03190582
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of TJ-8117(Onpi-to), a drug for renal failure (I): Plasma concentration, distribution and excretion of [3H]-(−)epicatechin 3-O-gallate in rats and dogs

Abstract: TJ-8117 (Onpi-to) is an herbal medicine extracted from a mixture of five crude medicinals (Rhei Rhizoma, Glycyrrhizae Radix, Ginseng Radix, Zingiberis Rhizoma and Aconiti Tuber), which has been developed as a drug for chronic renal failure. (-)Epicatechin 3-O-gallate (ECG), one of the active components of TJ-8117, was labeled with tritium and added to TJ-8117. Pharmacokinetics in plasma, tissue distribution and excretion of radioactivity were investigated following a single oral administration of TJ-8117 conta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 4 publications
0
7
0
Order By: Relevance
“…, 2008). Although dose range is an important factor for dose proportionality (Takizawa et al. , 2004), hepatic blood flow may have a direct influence on this for drugs such as propofol.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…, 2008). Although dose range is an important factor for dose proportionality (Takizawa et al. , 2004), hepatic blood flow may have a direct influence on this for drugs such as propofol.…”
Section: Discussionmentioning
confidence: 99%
“…Dose proportionality is a desirable property as it makes predicting the effects of dose adjustments easier (Hummel et al, 2008). It may be mainly affected by dose range, but not by species or size (Takizawa et al, 2004). In our previous study, reformulated microemulsion propofol showed nonlinear pharmacokinetics over the dose range of 0.5-1.5 mg·kg -1 ·min -1 in rats (Lee et al, 2008).…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…Using tritiated reducing agents (NaBT 4 and T-L-Selectride ® ), (+)-[3-3 H]-catechin and (-)-[3-3 H]-epicatechin were obtained with specific activities of 5 mCi.g -1 and 7.5 mCi.g -1 respectively. Takizawa et al [29] briefly described the synthetic route to (-)-[3-3 H]-epicatechin-3-O-gallate ((-)-[3-3 H]ECG) via the reduction of the protected ketone 1 (prepared according to Déprez et al [21]). The 4-bromo derivative 7 was first treated overnight with NaBT 4 , followed by additional NaBH 4 for 3 h. This process contributed to reducing the usage of NaBT 4 markedly.…”
Section: H-labelled Flavan-3-ols and Flavan-34-diolsmentioning
confidence: 99%
“…Synthesis of (-)-4-tritio-epigallocatechin-3-O-gallate ((-)-[4-3 H]EGCG) was reported by Kohri et al using a modification of the procedure developed for the preparation of the 4-deuterio analogue (see Scheme 3) [27]. Esterification with 3,4,5tris(benzyloxy)benzoyl chloride followed by deprotection (H 2 , Pd/C) finally afforded (-)-[3-3 H]ECG (Scheme 5) [29]. The synthetic (-)-[4-3 H]EGCG showed 99.5% radiochemical purity and a specific activity of 13 Ci/mmol.…”
Section: H-labelled Flavan-3-ols and Flavan-34-diolsmentioning
confidence: 99%